Eutilex.Co.,Ltd

KOSDAQ:A263050 Voorraadrapport

Marktkapitalisatie: ₩71.7b

Eutilex.Co.Ltd Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Byoung S. Kwon

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO2.3yrs
Eigendom CEO15.1%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Geen updates

Recent updates

Despite Lacking Profits Eutilex.Co.Ltd (KOSDAQ:263050) Seems To Be On Top Of Its Debt

Aug 07
Despite Lacking Profits Eutilex.Co.Ltd (KOSDAQ:263050) Seems To Be On Top Of Its Debt

Is Eutilex.Co.Ltd (KOSDAQ:263050) A Risky Investment?

Apr 15
Is Eutilex.Co.Ltd (KOSDAQ:263050) A Risky Investment?

Could The Eutilex.Co.,Ltd. (KOSDAQ:263050) Ownership Structure Tell Us Something Useful?

Feb 05
Could The Eutilex.Co.,Ltd. (KOSDAQ:263050) Ownership Structure Tell Us Something Useful?

CEO

Byoung S. Kwon

2.3yrs

Tenure

Dr. Byoung S. Kwon, Ph.D. is the Founder and serves as Chief Executive Officer of Eutilex Co., Ltd. Dr. Kwon serves as Endowed Investigator at the Division of Cell and Immunobiology of R&D Center for Cance...